These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17272226)

  • 1. Hypofractionation in radiotherapy.
    Pedraza Muriel V
    Clin Transl Oncol; 2007 Jan; 9(1):21-7. PubMed ID: 17272226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact on oncology of the interaction of radiation therapy and radiobiology.
    Pedraza Muriel V
    Clin Transl Oncol; 2006 Feb; 8(2):83-93. PubMed ID: 16632421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biologic effects of high doses per fraction].
    Grellier N; Belkacemi Y
    Cancer Radiother; 2020 Apr; 24(2):153-158. PubMed ID: 32089502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The radiobiology of hypofractionation.
    Nahum AE
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):260-9. PubMed ID: 25797579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An historical survey of radiobiology and radiotherapy with fast neutrons.
    Field SB
    Curr Top Radiat Res Q; 1976 Jan; 11(1):1-86. PubMed ID: 1106959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology.
    Yang Y; Xing L
    Med Phys; 2005 Dec; 32(12):3666-77. PubMed ID: 16475766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radiobiology of targeted radiotherapy.
    Wheldon TE; O'Donoghue JA
    Int J Radiat Biol; 1990 Jul; 58(1):1-21. PubMed ID: 1973428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.
    Mohan R; Wu Q; Manning M; Schmidt-Ullrich R
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):619-30. PubMed ID: 10701741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dose fractionation in cancer radiotherapy].
    Pedraza Muriel V
    An R Acad Nac Med (Madr); 2012; 129(2):443-55; discussion 455-6. PubMed ID: 24298859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated irradiation for non-small cell lung cancer.
    Abratt RP; Bogart JA; Hunter A
    Lung Cancer; 2002 Jun; 36(3):225-33. PubMed ID: 12009230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration.
    Antipas VP; Stamatakos GS; Uzunoglu NK; Dionysiou DD; Dale RG
    Phys Med Biol; 2004 Apr; 49(8):1485-504. PubMed ID: 15152687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cord response to altered fractionation and re-irradiation: radiobiological considerations and role of bioeffect models.
    Supe SS; Ganesh KM; Naveen T; Jacob S; Sankar BN
    J Cancer Res Ther; 2006; 2(3):105-18. PubMed ID: 17998688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
    Sminia P; Schneider CJ; Fowler JF
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: total doses in fractionated radiotherapy--implications of new radiobiological data.
    Fowler JF
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Aug; 46(2):103-20. PubMed ID: 6381354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative clinical radiobiology of early and late lung reactions.
    Bentzen SM; Skoczylas JZ; Bernier J
    Int J Radiat Biol; 2000 Apr; 76(4):453-62. PubMed ID: 10815624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1549-57. PubMed ID: 11121661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling late effects in hypofractionated stereotactic radiotherapy.
    Hoban PW; Jones LC; Clark BG
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):199-210. PubMed ID: 9989527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionation and therapeutic ratio with neutron therapy.
    Courdi A
    Bull Cancer Radiother; 1996; 83 Suppl():64s-7s. PubMed ID: 8949754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Evolution of Tumour Composition During Fractionated Radiotherapy: Implications for Outcome.
    Lewin TD; Maini PK; Moros EG; Enderling H; Byrne HM
    Bull Math Biol; 2018 May; 80(5):1207-1235. PubMed ID: 29488054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.